Medtrade Products, Ltd.
Medtrade is a global medical device company based in the UK, dedicated to saving and improving lives through innovative solutions in wound care, trauma, and hemostasis. With a focus on tackling global health challenges, Medtrade provides advanced manufacturing, regulatory, and marketing support to distribution partners worldwide.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Hemostatic granules
Sterile granular hemostat based on chitosan designed to conform to irregular wounds and rapidly induce clotting without exothermic reaction.
Hemostatic gauze and ribbon
Gauze and ribbon dressings with bonded hemostatic granules for rapid packing and haemostasis in severe bleeding scenarios; ribbon offers a low-profile format for narrow wounds.
Multi-layer silicone-faced foam dressings
Five-layer foam dressings combining silicone-facing and superabsorbent cores to manage exudate, reduce pressure and provide extended wear; available in antibacterial silver variants.
Gelling fibre dressings (chitosan-based)
Fibrous dressing that converts to a soft gel on contact with wound exudate, providing absorbency, wet integrity for atraumatic removal and MMP binding; available with ionic silver.
Chlorhexidine gluconate IV protective foam discs
Absorbent foam discs impregnated with chlorhexidine gluconate for application around vascular access devices to reduce risk of catheter-related bloodstream infections, with multi-day antimicrobial activity.
Silicone wound contact layer
Non-adherent silicone contact layer for protecting new tissue and intact skin and for use with negative pressure wound therapy.
Hemostatic granules
Sterile granular hemostat based on chitosan designed to conform to irregular wounds and rapidly induce clotting without exothermic reaction.
Hemostatic gauze and ribbon
Gauze and ribbon dressings with bonded hemostatic granules for rapid packing and haemostasis in severe bleeding scenarios; ribbon offers a low-profile format for narrow wounds.
Multi-layer silicone-faced foam dressings
Five-layer foam dressings combining silicone-facing and superabsorbent cores to manage exudate, reduce pressure and provide extended wear; available in antibacterial silver variants.
Gelling fibre dressings (chitosan-based)
Fibrous dressing that converts to a soft gel on contact with wound exudate, providing absorbency, wet integrity for atraumatic removal and MMP binding; available with ionic silver.
Chlorhexidine gluconate IV protective foam discs
Absorbent foam discs impregnated with chlorhexidine gluconate for application around vascular access devices to reduce risk of catheter-related bloodstream infections, with multi-day antimicrobial activity.
Silicone wound contact layer
Non-adherent silicone contact layer for protecting new tissue and intact skin and for use with negative pressure wound therapy.
Services
Design, prototyping, testing and regulatory submission support through to product commercialisation for woundcare, trauma and hemostasis products.
Private-label production and supply of advanced wound care and hemostatic products with flexible manufacturing scale and branding for distribution partners.
Support for regulatory strategy, CE marking, FDA clearances and operation under an ISO 13485 quality management system.
Management of international supplier networks and partner onboarding, including ethical sourcing checks and supplier code of conduct enforcement.
Collaborative R&D engagements with clinicians and key opinion leaders to develop solutions for biofilm, chronic wounds, infection prevention and bleeding control.
Design, prototyping, testing and regulatory submission support through to product commercialisation for woundcare, trauma and hemostasis products.
Private-label production and supply of advanced wound care and hemostatic products with flexible manufacturing scale and branding for distribution partners.
Support for regulatory strategy, CE marking, FDA clearances and operation under an ISO 13485 quality management system.
Management of international supplier networks and partner onboarding, including ethical sourcing checks and supplier code of conduct enforcement.
Collaborative R&D engagements with clinicians and key opinion leaders to develop solutions for biofilm, chronic wounds, infection prevention and bleeding control.
Expertise Areas
- Advanced wound care product development
- Hemostat development and manufacturing
- Medical dressing materials and absorbent technologies
- Postpartum haemorrhage interventions
Key Technologies
- Chitosan-based hemostatic materials
- Multi-layer foam dressing systems with silicone adhesive
- Gelling fibre (moisture-activated) dressings
- Antimicrobial-impregnated foam (chlorhexidine / ionic silver)
News & Updates
CEO Russ Mably recognized for his contributions to the medical device industry and the impact of Medtrade's products.
CEO Russ Mably recognized for his contributions to the medical device industry and the impact of Medtrade's products.